WNK1 and ovarian serous cystadenocarcinoma: Analysis of the Ovarian Serous Cystadenocarcinoma dataset (TCGA, Firehose Legacy) using the cBioportal genomic database40 showed the presence of WNK1 gene amplifications (12.1%) or gains (45.1%) in the ovarian tumours (n = 579) (Figure 2B, upper panel), as well as WNK1 mRNA upregulation in 16.1% of the cases (n = 304) (Figure 2B, lower panel).